ASLAN Pharmaceuticals Limited (ASLN) Financials
ASLN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 24.6 million | 37.9 million |
| 2023-12-31 | 24.6 million | 37.9 million |
| 2023-09-30 | 44.6 million | 45.5 million |
| 2023-06-30 | 55.2 million | 48.8 million |
ASLN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | ? | ? |
| 2023-12-31 | ? | ? |
| 2023-09-30 | ? | ? |
| 2023-06-30 | ? | ? |
ASLN Net Income
No data available :(
ASLN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 21.3 million | - | - |
| 2023-12-31 | - | - | 226187 |
| 2023-09-30 | 40.8 million | - | 299689 |
| 2023-06-30 | 40.9 million | - | 68214 |
ASLN Shares Outstanding
ASLN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | - | 9.6 million | 3.2 million | - |
| 2023-12-31 | - | 9.6 million | 3.2 million | - |
| 2023-09-30 | - | 7.2 million | 3.2 million | - |
| 2023-06-30 | - | 11.6 million | 2.8 million | - |
ASLN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | - | - |
| 2023-12-31 | - | - |
| 2023-09-30 | - | - |
| 2023-06-30 | 12.0 million | - |
ASLN
Price: $0.46
52 week price:
Earnings Per Share: -3.00 USD
P/E Ratio: -0.19
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 108290
Market Capitalization: 9.4 million